GAGE1 and prostate adenocarcinoma: At the same time, GAGE1 showed a similar effect in five cancer types, including kidney chromophobe, kidney renal papillary cell carcinoma, liver hepatocellular carcinoma, lung squamous cell carcinoma, and prostate adenocarcinoma (see S9 Fig and S4 File).